Figure 3
From: High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
(A) The overall survival of 139 ovarian carcinoma patients with early and advanced stages (P=0.006). (B) The OS of 139 ovarian carcinoma patients with optimal and suboptimal debulking surgery (P<0.001). (C) The OS of 139 ovarian carcinoma patients with time to normal CA125 level less and longer than 63 days (P<0.001). (D) The OS of 139 ovarian carcinoma patients with high- and low-expressed mesothelin levels (P<0.001).
